%0 Journal Article
%T The surge in biosimilars: considerations for effective
pharmacovigilance and EU regulation
%A Bego£ża Calvo
%A Enrique Echevarria
%A Javier Martinez-Gorostiaga
%J Archive of "Therapeutic Advances in Drug Safety".
%D 2018
%R 10.1177/2042098618790442
%X The development of biosimilars is growing rapidly, especially in Europe. They are a cost-effective alternative to original biological medicines and can help improve patient access to these therapies
%K biologics
%K biosimilars
%K immunogenicity
%K interchangeability
%K pharmacovigilance
%K regulatory requirements
%K safety
%K traceability
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166315/